WeVote

Bill

Bill

S 7460

Directs the commissioner of health to establish at least 4 maternal-infant care centers in areas of need for infants suffering from drug withdrawal as a result of in utero exposure

2025 Regular Session Introduced by Jake Ashby and 6 co-sponsors

Bill S 7460 mandates at least four maternal-infant care centers to support infants with drug withdrawal, improving health outcomes for affected families in high-need areas.

ADVANCED TO THIRD READING
0
WeVote Research Nonpartisan
Bill Summary · S 7460

Summary of Bill S 7460

Bill Overview

  • Bill Number: S 7460
  • Title: Directs the commissioner of health to establish at least 4 maternal-infant care centers in areas of need for infants suffering from drug withdrawal as a result of in utero exposure
  • Status: REPORTED AND COMMITTED TO FINANCE
  • Introduced: April 17, 2025
  • Classification: Bill

Purpose and Intent

The primary purpose of Bill S 7460 is to address the growing concern of infants suffering from drug withdrawal due to in utero exposure. The bill aims to improve maternal and infant health outcomes by establishing specialized care centers that provide necessary support and treatment for affected infants.

Key Provisions

  • Establishment of Care Centers: The bill mandates the commissioner of health to establish a minimum of four maternal-infant care centers. These centers will be strategically located in areas identified as having significant needs for such services.
  • Focus on Drug Withdrawal: The centers will specifically cater to infants experiencing withdrawal symptoms from drugs they were exposed to during pregnancy. This includes providing medical care, support services, and resources for families.
  • Assessment of Areas of Need: The bill emphasizes the importance of identifying geographic areas with high incidences of drug exposure in infants, ensuring that resources are allocated where they are most needed.

Impact

  • Target Population: The bill directly impacts infants suffering from drug withdrawal and their families. By providing specialized care, it aims to improve health outcomes for these vulnerable populations.
  • Healthcare Providers: The establishment of maternal-infant care centers will also affect healthcare providers, as they may be involved in the treatment and support of infants and their families.
  • Community Health: The bill is expected to enhance community health by addressing the specific needs of infants affected by drug exposure, potentially reducing long-term health issues associated with such conditions.

Procedural Aspects

  • Legislative Actions:
    • April 17, 2025: The bill was introduced and referred to the Health Committee.
    • May 13, 2025: The bill was reported and committed to the Finance Committee for further consideration.

Related Bills

This bill is part of a broader legislative effort to address maternal and infant health issues, with related bills from prior sessions including:
- S 2815
- S 5480
- S 1409
- S 266

These related bills may provide additional context or complementary measures aimed at improving health outcomes for mothers and infants.

Conclusion

Bill S 7460 represents a proactive approach to addressing the critical issue of drug withdrawal in infants due to in utero exposure. By establishing dedicated care centers, the bill seeks to provide essential support and improve health outcomes for affected infants and their families. The ongoing legislative process will determine the final implementation and funding of these initiatives.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.